A study of acute toxicity of newly synthesized compound on adult hydrobiont Danio rerio

From ancient times the people used different poisons as a treatment for diseases of different genesis. To date, almost nothing has changed. One of the main conditions for the development of a new drug is its low toxicity. Literature analysis has shown that 1,2,4-triazole-3-thione derivatives are low...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Safonov (Author), Yu. V. Karpenko (Author), Ye. H. Knysh (Author)
Format: Book
Published: Zaporozhye State Medical University, 2021-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_0b1037f65e5245d099c61b7c4e455f4f
042 |a dc 
100 1 0 |a A. A. Safonov  |e author 
700 1 0 |a Yu. V. Karpenko  |e author 
700 1 0 |a Ye. H. Knysh  |e author 
245 0 0 |a A study of acute toxicity of newly synthesized compound on adult hydrobiont Danio rerio 
260 |b Zaporozhye State Medical University,   |c 2021-03-01T00:00:00Z. 
500 |a 10.14739/2409-2932.2021.1.226789 
500 |a 2306-8094 
500 |a 2409-2932 
520 |a From ancient times the people used different poisons as a treatment for diseases of different genesis. To date, almost nothing has changed. One of the main conditions for the development of a new drug is its low toxicity. Literature analysis has shown that 1,2,4-triazole-3-thione derivatives are low-toxic compounds and exhibit a wide range of pharmacological activities. The aim of this work was the investigate acute toxicity LC50 in vivo of sodium 2-((4-amino-5-(thiophen-2-ylmethyl)-4H-1,2,4-triazole-3-yl)thio)acetate on the Zebrafish (Danio rerio) aquatic model according to OECD instruction № 203. Materials and methods. Determination of acute toxicity LC50 of the test compound was performed in vivo on a model of the aquatic organism Zebrafish (Danio rerio) according to the instruction OECD № 203 (Fish, Acute Toxicity Test) for testing chemical compounds (acute toxicity test on fish from 10.12.2009). It was used fish 2 months of age, 11.8 ± 0.1 mm long, and weighing 2.6 ± 0.2 g in the experiment. The concentration of the test compound ranged from 5.0 mg/l to 100.0 mg/l. Test water-soluble compounds were dissolved in distilled water. Each mini-aquarium with a certain dose of the compound contained at least 7 individuals of Danio rerio. During the experiments, the fish were kept on a diet for a test 96 hours and their mortality was checked every 24, 48, 72 and 96 hours. Statistical analysis of the results was performed using the program Statistica 6. Results. According to the obtained data, graphs of the dependence of the concentration on the fish mortality percentage were constructed. Then the corresponding values of LC50 sodium 2-((4-amino-5-(thiophen-2-ylmethyl)-4H-1,2,4-triazole-3-yl)thio)acetate were calculated. According to the acute toxicity of LC50 (96 hours) of sodium 2-((4-amino-5-(thiophen-2-ylmethyl)-4H-1,2,4-triazole-3-yl)thio)acetate, which according to the classification of D. R. Passino and co-authors allowed it to be classified as a moderately toxic compound. Conclusions. The acute toxicity LC50 in vivo of sodium 2-((4-amino-5-(thiophen-2-ylmethyl)-4H-1,2,4-triazole-3-yl)thio)acetate on the Zebrafish (Danio rerio) aquatic model was investigated. The research was conducted in accordance with the national "General Ethical Principles of Animal Experimentation" approved by the First National Congress on Bioethics and the "Bioethical Expertise of Preclinical and Other Animal Research". The highest fish mortality occurs on the last day of observation (96 hours). The highest number of Zebrafish deaths is at a minimum concentration of the substance. The acute toxicity LC50 (96 hours) of the test substance was 4.5364 mg/l. 
546 |a EN 
546 |a RU 
546 |a UK 
690 |a acute toxicity tests 
690 |a 1 
690 |a 2 
690 |a 4-triazole 
690 |a salts 
690 |a heterocyclic compounds 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, Vol 14, Iss 1, Pp 68-72 (2021) 
787 0 |n http://pharmed.zsmu.edu.ua/article/view/226789/226526 
787 0 |n https://doaj.org/toc/2306-8094 
787 0 |n https://doaj.org/toc/2409-2932 
856 4 1 |u https://doaj.org/article/0b1037f65e5245d099c61b7c4e455f4f  |z Connect to this object online.